Quick Answer
NIKA PHARMACEUTICALS, INC reported Operating Income of -$76.4 thousand for fiscal year 2025.
NIKA PHARMACEUTICALS, INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$76.4K | +20.2% |
| 2024 | -$95.8K | -47.8% |
| 2023 | -$64.8K | +98.0% |
| 2022 | -$3.18M | -21540.3% |
| 2021 | -$14.7K | -65.2% |
| 2020 | -$8.9K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.0K | +4.4% | +56.5% |
| June 30, 2025 | -$18.4K | +18.2% | -42.0% |
| March 31, 2025 | -$12.9K | +71.8% | -54.7% |
| September 30, 2024 | -$8.4K | +17.5% | +62.7% |
| June 30, 2024 | -$22.5K | -121.4% | +51.1% |
| March 31, 2024 | -$46.0K | -134.8% | -353.0% |
| September 30, 2023 | -$10.1K | -60.0% | +0.0% |
| June 30, 2023 | -$10.1K | +99.7% | +48.2% |
- NIKA PHARMACEUTICALS, INC showed an increase of +20.2% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, NIKA PHARMACEUTICALS, INC’s operating income has declined by 757.7% (from -$8.9 thousand to -$76.4 thousand).
- The most recent figure is from NIKA PHARMACEUTICALS, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: